Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler.
JPMorgan says this U.S. chemical stock stands to benefit from Iran war supply disruption
Eastman Chemical shares will rise thanks to higher prices of several chemicals that it produces, according to the bank.
General Motors is trading at attractive levels after pullback, Deutsche Bank says
Shares have edged down more than 2% since the Iran war began, fueled by concerns about rising shipping costs and potential supply shocks.
Buy the dip on Ford as aluminum fears are ‘overblown’, says UBS
The investment bank upgraded the automaker to buy from neutral.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
Stocks staged a comeback on Monday as traders held out hope for a U.S.-Iran peace deal. The S&P 500 erased its losses since the start of the conflict.
Investor Joe Terranova says one public stock is a back door way to play the booming fortunes of private Anthropic
Zoom, which has a stake in Anthropic, is a good way to play the red-hot private AI firm, according to Virtus Investment Partners’ Joe Terranova.
Wells Fargo Investment Institute says now is the time to lock in 5% yields on these bonds
Recent volatility has created a compelling entry point for investors to snap up these high-quality bonds, according to Wells Fargo Investment Institute.
Wind energy ETF technical catalyst could herald further gains, Katie Stockton says
FAN recently cleared its February high, which gives it a better chance of clearing the 2021 peak over the coming weeks.
These chip stocks on Josh Brown’s list have been home runs, and can continue rising
Josh Brown and Sean Russo run through two top performers on their Best Stocks list.
Oil prices will likely stay higher for longer. An options trade on this energy stock set to benefit
Michael Khouw breaks down this call spread risk reversal options trade.